Effect of gefitinib (ZD1839) on metastatic brain tumour.
Takahashi
Hidenori
H
Ohrui
Takashi
T
Ebihara
Satoru
S
Yamada
Mitsuhiro
M
Sasaki
Hidetada
H
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000627:therapeutic use*; D016879:Salvage Therapy; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D011799:Quinazolines; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib